Azenta, Inc. (LON:0HQ1)
London · Delayed Price · Currency is GBP · Price in USD 38.83
+0.85 (2.24%)
Jan 14, 2026, 4:15 PM GMT
Azenta Market Cap
Azenta has a market cap or net worth of 1.35 billion as of January 15, 2026. Its market cap has decreased by -28.25% in one year.
Market Cap
1.35B
Enterprise Value
991.83M
Revenue
441.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
38.83
Market Cap Chart
Since February 2, 1995, Azenta's market cap has increased from 21.97M to 1.35B, an increase of 6,048.16%. That is a compound annual growth rate of 14.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 1.32B | 16.00% |
| Dec 31, 2025 | 1.14B | -37.72% |
| Dec 31, 2024 | 1.82B | -35.96% |
| Dec 29, 2023 | 2.85B | -14.60% |
| Dec 30, 2022 | 3.34B | -41.51% |
| Dec 31, 2021 | 5.70B | 54.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 217.25B |
| GSK plc | 74.55B |
| Haleon | 32.28B |
| Smith & Nephew | 10.22B |
| Convatec Group | 4.60B |
| Hikma Pharmaceuticals | 3.41B |
| HUTCHMED (China) | 1.90B |
| Genus | 1.68B |